Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giant Biogene Holding CoHKSE:02367 +1.24%85 Dividend Payout Ratio is 0.87 as of Dec. 2025, which is 211% above its 10-year median of 0.28. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.03 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,002 Consumer Packaged Goods companies, Giant Biogene Holding Co ranks better than 61.38% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Giant Biogene Holding Co's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.87.
The historical rank and industry rank for Giant Biogene Holding Co's Dividend Payout Ratio or its related term are showing as below:
HKSE:02367'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22 Med: 0.28 Max: 0.36
Current: 0.36
During the past 7 years, the highest Dividend Payout Ratio of Giant Biogene Holding Co was 0.36. The lowest was 0.22. And the median was 0.28.
HKSE:02367's Dividend Payout Ratio is ranked better than 61.38% of 1002
companies
in the Consumer Packaged Goods industry
Industry Median: 0.44
vs HKSE:02367: 0.36
During the past 7 years, the highest Trailing Annual Dividend Yield of Giant Biogene Holding Co was 2.61%. The lowest was 0.56%. And the median was 1.24%.
Giant Biogene Holding Co (HKSE:02367) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Giant Biogene Holding Co Dividend Payout Ratio Related Terms
Giant Biogene Holding Co Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Giant Biogene Holding Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co Dividend Payout Ratio Chart
HKSE:02367 vs PG, CL, EL: Dividend Payout Ratio Comparison
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co Dividend Payout Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Dividend Payout Ratio falls into.
Giant Biogene Holding Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Giant Biogene Holding Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co (HKSE:02367) has a Dividend Payout Ratio of 0.87 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Giant Biogene Holding Co and its competitors. This is 211% above median its historical median of 0.28. Over the past decade, Giant Biogene Holding Co's Dividend Payout Ratio has ranged from 0.22 to 0.36. According to the industry distribution chart, Giant Biogene Holding Co ranks #387 out of 1002 companies in the Consumer Packaged Goods industry, placing it in the top 38.6%.
Is Giant Biogene Holding Co's Dividend Payout Ratio too high?
Giant Biogene Holding Co's current Dividend Payout Ratio of 0.87 is 211% above median its 10-year median of 0.28. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 0.36. The Consumer Packaged Goods industry median Dividend Payout Ratio is 0.44. Giant Biogene Holding Co's value of 0.87 is 97.7% above this industry median. Based on the distribution chart, Giant Biogene Holding Co ranks #387 out of 1002 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Dividend Payout Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Giant Biogene Holding Co ranks #387 out of 1002 companies for Dividend Payout Ratio. This puts Giant Biogene Holding Co in the upper half of its industry. The industry median Dividend Payout Ratio is 0.44. Giant Biogene Holding Co's value of 0.87 is 97.7% above this benchmark. Historically, Giant Biogene Holding Co's own Dividend Payout Ratio has ranged from 0.22 to 0.36 over the past decade. While the company's 10-year median is 0.28 vs. the industry median of 0.44, Giant Biogene Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Consumer Packaged Goods company?
The median Dividend Payout Ratio among Consumer Packaged Goods companies is 0.44, based on 1,002 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giant Biogene Holding Co's current Dividend Payout Ratio of 0.87 is 97.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Giant Biogene Holding Co and its competitors. For the Consumer Packaged Goods industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giant Biogene Holding Co's current Dividend Payout Ratio is 0.87, which is 211% above median its own 10-year median of 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.03, compared to a current price of HK$24.46 — trading 64% below its estimated fair value. The current Dividend Payout Ratio is 0.87, which is 211% above median its 10-year median of 0.28 and 97.7% above the Consumer Packaged Goods industry median of 0.44. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Dividend Payout Ratio is 0.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?
Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued.
The current stock price of HK$24.46 is trading 64% below its estimated GF Value™ of HK$68.03.
GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.
Key valuation signals for HKSE:02367:
Dividend Payout Ratio: 0.87 (211% above median its 10-year median of 0.28)
GF Value™: HK$68.03 vs. price of HK$24.46 (64% below fair value)
Industry Position: 97.7% above the Consumer Packaged Goods median (#387 of 1002)
No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score
Get the complete analysis for HKSE:02367
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02367 has been successfully added to your 
